![right-img2](https://vidmaxviral.com/templates/vidmax_2020/images/icons/right-img2.png.pagespeed.ce.bp2sl7AN9J.png)
![right-img4](https://vidmaxviral.com/templates/vidmax_2020/images/icons/right-img4.png.pagespeed.ce.G7eu2_Ek66.png)
In a recent interview, Dr. Sabine Hazan, a leading expert in microbiome research, revealed that people who develop severe cases of COVID-19 are missing a specific type of gut bacteria known as Bifidobacteria longum. This bacteria plays a crucial role in maintaining a healthy gut microbiome and immune system. Dr. Hazan stated, 'We discovered that patients with COVID-19 have a significant depletion of their Bifidobacteria longum. This bacteria is very important for producing short-chain fatty acids that are needed to keep the immune system healthy.'
Dr. Hazan also discussed her research into fecal microbiota transplants (FMTs) as a potential treatment for COVID-19. FMTs involve transferring fecal matter from a healthy donor to a patient's gastrointestinal tract in order to restore a healthy microbiome. According to Dr. Hazan, 'We have completed over 200 FMTs and have seen a 100% success rate in treating patients with COVID-19.' She added, 'It's not the fecal matter that is the treatment, but the bacteria within it that is needed for the immune system to function properly.'
The interview with Dr. Hazan has brought attention to the importance of gut health in relation to COVID-19 and the potential for FMTs to be used as a treatment option. While more research is needed to fully understand the role of gut bacteria in COVID-19, Dr. Hazan's work has provided valuable insights into potential treatment options. As she stated, 'We need to look beyond traditional treatments and start looking at how we can use the microbiome to help our immune system fight against this virus.'